Benign Prostatic Hyperplasia (BPH) Therapeutics – Pipeline Analysis 2019, Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments: Pharma Proff
09 mai 2019 02h56 HE
|
Prescient & Strategic Intelligence
NEW YORK, May 09, 2019 (GLOBE NEWSWIRE) -- According to a new research report titled “Benign Prostatic Hyperplasia (BPH) Therapeutics – Pipeline Analysis 2019, Clinical Trials and Results, Patents,...